Annual Cash & Cash Equivalents
$203.70 M
+$56.60 M+38.48%
December 31, 2023
Summary
- As of February 7, 2025, IOSP annual cash & cash equivalents is $203.70 million, with the most recent change of +$56.60 million (+38.48%) on December 31, 2023.
- During the last 3 years, IOSP annual cash & cash equivalents has risen by +$98.40 million (+93.45%).
- IOSP annual cash & cash equivalents is now at all-time high.
Performance
IOSP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$303.80 M
+$63.60 M+26.48%
September 30, 2024
Summary
- As of February 7, 2025, IOSP quarterly cash and cash equivalents is $303.80 million, with the most recent change of +$63.60 million (+26.48%) on September 30, 2024.
- Over the past year, IOSP quarterly cash and cash equivalents has increased by +$63.60 million (+26.48%).
- IOSP quarterly cash and cash equivalents is now at all-time high.
Performance
IOSP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IOSP Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +38.5% | +26.5% |
3 y3 years | +93.5% | +187.7% |
5 y5 years | +65.5% | +188.5% |
IOSP Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +43.6% | at high | +325.5% |
5 y | 5-year | at high | +169.1% | at high | +422.0% |
alltime | all time | at high | +1365.5% | at high | +2085.6% |
Innospec Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $303.80 M(+26.5%) |
Jun 2024 | - | $240.20 M(-11.1%) |
Mar 2024 | - | $270.10 M(+32.6%) |
Dec 2023 | $203.70 M(+38.5%) | $203.70 M(-1.7%) |
Sep 2023 | - | $207.20 M(+24.9%) |
Jun 2023 | - | $165.90 M(+12.5%) |
Mar 2023 | - | $147.50 M(+0.3%) |
Dec 2022 | $147.10 M(+3.7%) | $147.10 M(+46.4%) |
Sep 2022 | - | $100.50 M(+40.8%) |
Jun 2022 | - | $71.40 M(-32.4%) |
Mar 2022 | - | $105.60 M(-25.5%) |
Dec 2021 | $141.80 M(+34.7%) | $141.80 M(+59.0%) |
Sep 2021 | - | $89.20 M(-5.5%) |
Jun 2021 | - | $94.40 M(-19.3%) |
Mar 2021 | - | $117.00 M(+11.1%) |
Dec 2020 | $105.30 M(+39.1%) | $105.30 M(+58.1%) |
Sep 2020 | - | $66.60 M(+14.4%) |
Jun 2020 | - | $58.20 M(-14.5%) |
Mar 2020 | - | $68.10 M(-10.0%) |
Dec 2019 | $75.70 M(-38.5%) | $75.70 M(-31.4%) |
Sep 2019 | - | $110.30 M(+4.0%) |
Jun 2019 | - | $106.10 M(-14.1%) |
Mar 2019 | - | $123.50 M(+0.3%) |
Dec 2018 | $123.10 M(+36.5%) | $123.10 M(+34.7%) |
Sep 2018 | - | $91.40 M(+38.5%) |
Jun 2018 | - | $66.00 M(-15.5%) |
Mar 2018 | - | $78.10 M(-13.4%) |
Dec 2017 | $90.20 M(-11.5%) | $90.20 M(+37.7%) |
Sep 2017 | - | $65.50 M(+34.2%) |
Jun 2017 | - | $48.80 M(+7.5%) |
Mar 2017 | - | $45.40 M(-55.4%) |
Dec 2016 | $101.90 M(-25.6%) | $101.90 M(-39.0%) |
Sep 2016 | - | $167.10 M(+9.1%) |
Jun 2016 | - | $153.20 M(+35.1%) |
Mar 2016 | - | $113.40 M(-17.2%) |
Dec 2015 | $136.90 M(+229.1%) | $136.90 M(+7.2%) |
Sep 2015 | - | $127.70 M(+98.6%) |
Jun 2015 | - | $64.30 M(+38.3%) |
Mar 2015 | - | $46.50 M(+11.8%) |
Dec 2014 | $41.60 M(-48.1%) | $41.60 M(-54.0%) |
Sep 2014 | - | $90.40 M(-1.1%) |
Jun 2014 | - | $91.40 M(+1.4%) |
Mar 2014 | - | $90.10 M(+12.3%) |
Dec 2013 | $80.20 M(+258.0%) | $80.20 M(+48.8%) |
Sep 2013 | - | $53.90 M(-1.5%) |
Jun 2013 | - | $54.70 M(+26.6%) |
Mar 2013 | - | $43.20 M(+92.9%) |
Dec 2012 | $22.40 M(-70.6%) | $22.40 M(-82.7%) |
Sep 2012 | - | $129.60 M(+22.5%) |
Jun 2012 | - | $105.80 M(+16.0%) |
Mar 2012 | - | $91.20 M(+19.7%) |
Dec 2011 | $76.20 M | $76.20 M(-42.3%) |
Sep 2011 | - | $132.10 M(+33.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $99.00 M(+10.1%) |
Mar 2011 | - | $89.90 M(-16.1%) |
Dec 2010 | $107.10 M(+56.1%) | $107.10 M(+8.4%) |
Sep 2010 | - | $98.80 M(+34.1%) |
Jun 2010 | - | $73.70 M(+14.8%) |
Mar 2010 | - | $64.20 M(-6.4%) |
Dec 2009 | $68.60 M(+393.5%) | $68.60 M(+36.7%) |
Sep 2009 | - | $50.20 M(+12.8%) |
Jun 2009 | - | $44.50 M(+25.4%) |
Mar 2009 | - | $35.50 M(+155.4%) |
Dec 2008 | $13.90 M(-42.8%) | $13.90 M(-8.6%) |
Sep 2008 | - | $15.20 M(-7.3%) |
Jun 2008 | - | $16.40 M(+16.3%) |
Mar 2008 | - | $14.10 M(-42.0%) |
Dec 2007 | $24.30 M(-76.2%) | $24.30 M(-14.1%) |
Sep 2007 | - | $28.30 M(-18.7%) |
Jun 2007 | - | $34.80 M(+0.3%) |
Mar 2007 | - | $34.70 M(-65.9%) |
Dec 2006 | $101.90 M(+47.9%) | $101.90 M(+10.9%) |
Sep 2006 | - | $91.90 M(+39.7%) |
Jun 2006 | - | $65.80 M(+10.2%) |
Mar 2006 | - | $59.70 M(-13.4%) |
Dec 2005 | $68.90 M(+106.9%) | $68.90 M(+6.7%) |
Sep 2005 | - | $64.60 M(+130.7%) |
Jun 2005 | - | $28.00 M(-38.6%) |
Mar 2005 | - | $45.60 M(+36.9%) |
Dec 2004 | $33.30 M(-27.8%) | $33.30 M(-4.3%) |
Sep 2004 | - | $34.80 M(-55.6%) |
Jun 2004 | - | $78.30 M(+15.3%) |
Mar 2004 | - | $67.90 M(+47.3%) |
Dec 2003 | $46.10 M(+72.7%) | $46.10 M(+4.5%) |
Sep 2003 | - | $44.10 M(+53.7%) |
Jun 2003 | - | $28.70 M(-8.3%) |
Mar 2003 | - | $31.30 M(+17.2%) |
Dec 2002 | $26.70 M(-37.9%) | $26.70 M(-13.9%) |
Sep 2002 | - | $31.00 M(+14.8%) |
Jun 2002 | - | $27.00 M(+6.3%) |
Mar 2002 | - | $25.40 M(-40.9%) |
Dec 2001 | $43.00 M(+14.1%) | $43.00 M(-2.3%) |
Sep 2001 | - | $44.00 M(+41.5%) |
Jun 2001 | - | $31.10 M(-52.9%) |
Mar 2001 | - | $66.00 M(+75.1%) |
Dec 2000 | $37.70 M(+1.3%) | $37.70 M(-8.9%) |
Sep 2000 | - | $41.40 M(-27.4%) |
Jun 2000 | - | $57.00 M(+32.6%) |
Mar 2000 | - | $43.00 M(+15.6%) |
Dec 1999 | $37.20 M(+40.4%) | $37.20 M(+44.2%) |
Sep 1999 | - | $25.80 M(+61.3%) |
Jun 1999 | - | $16.00 M(-48.9%) |
Mar 1999 | - | $31.30 M(+18.1%) |
Dec 1998 | $26.50 M | $26.50 M(-46.6%) |
Sep 1998 | - | $49.60 M(+18.1%) |
Jun 1998 | - | $42.00 M(+26.1%) |
Mar 1998 | - | $33.30 M |
FAQ
- What is Innospec annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Innospec?
- What is Innospec annual cash & cash equivalents year-on-year change?
- What is Innospec quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Innospec?
- What is Innospec quarterly cash and cash equivalents year-on-year change?
What is Innospec annual cash & cash equivalents?
The current annual cash & cash equivalents of IOSP is $203.70 M
What is the all time high annual cash & cash equivalents for Innospec?
Innospec all-time high annual cash & cash equivalents is $203.70 M
What is Innospec annual cash & cash equivalents year-on-year change?
Over the past year, IOSP annual cash & cash equivalents has changed by +$56.60 M (+38.48%)
What is Innospec quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IOSP is $303.80 M
What is the all time high quarterly cash and cash equivalents for Innospec?
Innospec all-time high quarterly cash and cash equivalents is $303.80 M
What is Innospec quarterly cash and cash equivalents year-on-year change?
Over the past year, IOSP quarterly cash and cash equivalents has changed by +$63.60 M (+26.48%)